摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Bromomethyl-6,7-dimethoxy-1-methyl-2(H)-quinoxalinone

中文名称
——
中文别名
——
英文名称
3-Bromomethyl-6,7-dimethoxy-1-methyl-2(H)-quinoxalinone
英文别名
3-(bromomethyl)-6,7-dimethoxy-1-methylquinoxalin-2-one
3-Bromomethyl-6,7-dimethoxy-1-methyl-2(H)-quinoxalinone化学式
CAS
——
化学式
C12H13BrN2O3
mdl
——
分子量
313.15
InChiKey
MAGGXASHVAMJCT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    51.1
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    丙戊酸3-Bromomethyl-6,7-dimethoxy-1-methyl-2(H)-quinoxalinone 生成 6,7-dimethoxy-1-methyl-3-(4-methyl-2-oxo-3-propan-2-ylpentyl)quinoxalin-2-one
    参考文献:
    名称:
    MATSUYAMA, KENJI;MIYAZAKI, CHACHIRO;YAMASHITA, TATSHYA;ISHIKAWA, MASATAKA, BUNSEHKI KAGAKU, 38,(1989) N1, S. T174-T178
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use
    申请人:Agouron Pharmaceuticals, Inc.
    公开号:US20020025976A1
    公开(公告)日:2002-02-28
    Diaminothiazole compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.
    噻唑化合物可调节和/或抑制特定蛋白激酶的活性。这些化合物及含有它们的药物组合物能够介导酪氨酸激酶信号传导,以调节和/或抑制不需要的细胞增殖。本发明还涉及含有这些化合物的药物组合物的治疗或预防用途,以及通过给予这些化合物的有效量来治疗癌症以及与不需要的血管生成和/或细胞增殖相关的其他疾病状态,如糖尿病视网膜病变、新生血管性青光眼、类风湿性关节炎和牛皮癣的方法。
  • INDICATOR FOR ASSESSING BODY ODOR, PROCESS FOR PRODUCING THE SAME, BODY ODOR ASSESSMENT METHOD, METHOD OF ASSESSING EFFICACIOUSNESS OF DEODORANT AND KIT FOR CONVENIENTLY ASSESING BODY ODOR
    申请人:Kao Corporation
    公开号:EP1553411A1
    公开(公告)日:2005-07-13
    An indicator material for assessing body odor of the present invention comprises at least one member selected from the group consisting of a substance (A) which is a β-hydroxycarboxylic acid compound represented by the formula (1), a substance (B) which is a derivative of the compound represented by the formula (1), a substance (C) which is an alcohol compound having a mercapto group at the 3-position represented by the formula (2),and a substance (D) which is a derivative of the compound represented by the formula (2). The present invention also provides a method of producing the compound represented by the formula (2) by incubating perspiration originated from a human in an environment with an oxygen concentration of 10 v/v% or less. The present invention also provides a kit for assessing body odor of a human, wherein the kit for assessing body odor of a human includes a coloration reagent which reacts with β-hydroxycarboxylic acid originated from perspiration of a human. wherein R1 is an alkyl having 1 to 4 carbons; R2 is a hydrogen atom or an alkyl having 1 to 4 carbons, and the total number of carbons in the formula (1) is 10 or less; wherein R3 is a hydrogen atom or methyl group; R4 is an alkyl group having 1 to 3 carbons; and R5 is a hydrogen atom or a methyl group, the total number of carbons is 8 or less.
    本发明的一种用于评估体味的指示剂材料包括至少一种选自以下组成的成员:一种物质(A),它是β-羟基羧酸化合物,由式(1)表示;一种物质(B),它是由式(1)表示的化合物的衍生物;一种物质(C),它是由式(2)表示的在3-位上具有巯基的醇化合物;以及一种物质(D),它是由式(2)表示的化合物的衍生物。本发明还提供了一种通过在氧气浓度为 10 v/v% 或更低的环境中培养人的汗液来生产式(2)所代表的化合物的方法。本发明还提供了一种用于评估人的体味的试剂盒,其中用于评估人的体味的试剂盒包括一种与源自人的汗液的β-羟基羧酸反应的着色试剂。 其中 R1 是具有 1 至 4 个碳原子的烷基;R2 是氢原子或具有 1 至 4 个碳原子的烷基,且式(1)中的碳原子总数为 10 或更少; 其中 R3 是氢原子或甲基;R4 是具有 1 至 3 个碳原子的烷基;R5 是氢原子或甲基,碳原子总数为 8 或更少。
  • Indicator for assessing body odor, process for producing the same, body odor assessment method, method of assessing efficaciousness of deodorant and kit for conveniently assessing body odor
    申请人:Hasegawa Yoshihiro
    公开号:US20060160240A1
    公开(公告)日:2006-07-20
    An indicator material for assessing body odor of the present invention comprises at least one member selected from the group consisting of a substance (A) which is a β-hydroxycarboxylic acid compound represented by the formula (1), a substance (B) which is a derivative of the compound represented by the formula (1), a substance (C) which is an alcohol compound having a mercapto group at the 3-position represented by the formula (2),and a substance (D) which is a derivative of the compound represented by the formula (2). The present invention also provides a method of producing the compound represented by the formula (2) by incubating perspiration originated from a human in an environment with an oxygen concentration of 10 v/v % or less. The present invention also provides a kit for assessing body odor of a human, wherein the kit for assessing body odor of a human includes a coloration reagent which reacts with β-hydroxycarboxylic acid originated from perspiration of a human.
    本发明的一种用于评估体味的指示剂材料包括至少一种选自以下组成的成员:一种物质(A),它是β-羟基羧酸化合物,由式(1)表示;一种物质(B),它是由式(1)表示的化合物的衍生物;一种物质(C),它是由式(2)表示的在3-位上具有巯基的醇化合物;以及一种物质(D),它是由式(2)表示的化合物的衍生物。本发明还提供了一种通过在氧气浓度为 10 v/v % 或更低的环境中培养人的汗液来生产式(2)所代表的化合物的方法。本发明还提供了一种用于评估人的体味的试剂盒,其中用于评估人的体味的试剂盒包括一种着色试剂,该试剂与源自人的汗液的β-羟基羧酸反应。
  • DIAMINOTHIAZOLES AND THEIR USE FOR INHIBITING PROTEIN KINASES
    申请人:AGOURON PHARMACEUTICALS, INC.
    公开号:EP1181283B1
    公开(公告)日:2005-02-02
  • COMPOSITIONS AND METHODS FOR DETECTION OF SOILS ON FABRICS
    申请人:The Sun Products Corporation
    公开号:EP2601048A2
    公开(公告)日:2013-06-12
查看更多